CSL Vifor and Travere Therapeutics Inc jointly announced today that FILSPARI has been granted conditional marketing authorization by the European Commission

Tetra Pharm Technologies and Glysious are excited to announce a new collaboration aiming to revolutionize transdermal drug delivery systems The partnership intends to enhance several of Tetra

Regeneration Biomedical Inc a company focused on developing stem cell therapies for neurodegenerative diseases has reached a significant milestone by dosing the first patient in a Phase

GenScript Biotech Corporation and Multiply Labs have teamed up to transform the cell therapy manufacturing process Their partnership focuses on automating the intricate cell isolation phase

Averoa a biopharmaceutical company focused on innovative therapeutic solutions for renal diseases has announced the submission of a marketing authorization application to the European Medicines

Ochre Bio a pioneer in the realm of drug development for chronic liver ailments has forged a partnership with Boehringer Ingelheim a prominent German pharmaceutical company Their joint efforts

BioAffinity Technologies Inc a biotechnology company focused on the need for noninvasive accurate tests for the detection of earlystage lung cancer and other lung diseases today announced David Elzi PhD has been named Vice President

Arrowhead Pharmaceuticals Inc announced today that it has dosed the first subjects in a Phase a clinical trial of AROCFB the companys investigational RNA interference therapeutic in up to healthy volunteers and patients with complement

Medicure Inc a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market announced today that through its subsidiary Medicure

Palisade Bio Inc a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune inflammatory and fibrotic diseases today announced it has entered